New Delhi: Delta variant of SARS-COV-2, which caused a large number of virus infections during the second Covid-19 wave, remained a dominant strain in circulation in the national capital.
It has been detected at least 80% of samples sent for genome sequencing by the Delhi government in the last three months.
In July, the data distributed by the Ministry of Health at the Delhi Disaster Management Authority Meeting (DDMA) showed that the Delta variant was detected at 83.3% of samples sent for genome sequencing.
In May and June, the variant was found at 81.7% and 88.6% of the sample, respectively.
In April, it was found at 53.9% of the sample.
The other “concern variant” detected in the sample sent by the Delhi government to the center of the national disease for the sorting of the genome is Alpha.
“The second wave of pandemics has not ended.
The dominance of the Delta variant between samples is this evidence.
This variant is still circulating.
We see fewer cases in Delhi because many people have been exposed to it,” said Dr.
Arun Gupta, Delhi’s medical council president, added that the dominance of variants Delta is the main reason behind a high everyday case throughout the country.
Delta variant (B.1.617.2) is a sub-genealogy of the Kappa variant (B.1.617), which was first detected in Maharashtra in October 2020.
Now it has spread to several parts of the world.
Scientists say Delta is not only transmitting compared to other variants, but also has a higher viral load and a breakthrough level of vaccination.
In a recent published study, the top scientists from NCDC, CSIR Institute of Genomics and Integrative Biology and Academy for scientific and innovative research noted, “…
previous infection, high seropositivity and inadequate partial vaccination.” This study concluded, “Strong public health measures will be needed globally for detention.” Dr.
Gupta, who is also a member of DDMA, said wearing a mask, keeping social and maintaining hand cleanliness is a must to prevent the spread of disease.
Also, the vaccination rate must rise.
“The third wave of pandemic may or may not come.
This will depend on further mutations in the Coronavirus novel and transmission,” he added.
Mutations or evolution of the SARS-COV-2 virus are mostly seen in patients compromised by immunity, such as those who suffer from cancer, TB and HIV, with persistent infections.
In an article published in the New England Journal of Medicine, the Top US scientists argue that increasing precautions must be taken to prevent Covid-19 transmission for patients compromised immunity in this setting to reduce this risk.
“Such patients must be prioritized because immunization is not only to protect them from SARS-COV-2, but also to reduce continuous infection,” he added.